BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38743007)

  • 1. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-Positive patients.
    Luo C
    Hepatology; 2024 May; ():. PubMed ID: 38743007
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk-A multinational cohort study of HBeAg-positive patients.
    He T; Zhang D
    Hepatology; 2024 Apr; ():. PubMed ID: 38607724
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
    Choi WM; Yip TC; Kim WR; Yee LJ; Brooks-Rooney C; Curteis T; Clark LJ; Jafry Z; Chen CH; Chen CY; Huang YH; Jin YJ; Jun DW; Kim JW; Park NH; Peng CY; Shin HP; Shin JW; Yang YH; Wong GL; Lim YS
    Hepatology; 2024 Jan; ():. PubMed ID: 38436992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of Patients with HBeAg-Positive.
    Choi WM; Lim YS
    Hepatology; 2024 Apr; ():. PubMed ID: 38607785
    [No Abstract]   [Full Text] [Related]  

  • 5. Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B.
    Choi WM; Kim GA; Choi J; Han S; Lim YS
    J Clin Invest; 2022 May; 132(10):. PubMed ID: 35358094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.
    Pan CQ; Chan S; Trinh H; Yao A; Bae H; Lou L
    World J Gastroenterol; 2015 May; 21(18):5524-31. PubMed ID: 25987775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.
    Jang H; Yoon JS; Park SY; Lee HA; Jang MJ; Kim SU; Sinn DH; Seo YS; Kim HY; Kim SE; Jun DW; Yoon EL; Sohn JH; Ahn SB; Shim JJ; Jeong SW; Cho YK; Kim HS; Nam JY; Lee YB; Kim YJ; Yoon JH; Zoulim F; Lampertico P; Dalekos GN; Idilman R; Sypsa V; Berg T; Buti M; Calleja JL; Goulis J; Manolakopoulos S; Janssen H; Papatheodoridis GV; Lee JH
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1343-1353.e16. PubMed ID: 34500103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver histological status and clinic outcome in HBeAg-negative chronic hepatitis B with low viral load].
    Deng DL; Jiang JN; Su MH; Wang RM; Zang WW; Ling XZ; Wei HL; Liang XS; Zhou HK; He WM; Guo RS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):1013-1017. PubMed ID: 34865348
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B.
    Choi WM; Kim GA; Choi J; Choi GH; Lee YB; Sinn DH; Lim YS
    Gut; 2024 Mar; 73(4):649-658. PubMed ID: 37813567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FEATURES OF THE RELATIONSHIP BETWEEN IMMUNOLOGICAL PARAMETERS, LEVEL OF VIRAL LOAD AND SEVERITY OF MORPHOLOGICAL CHANGES IN THE LIVER ACCORDING TO NON-INVASIVE TESTS IN HBEAG--NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B].
    Khelemendyk A; Riabokon E; Riabokon Y
    Georgian Med News; 2021 Oct; (319):76-81. PubMed ID: 34749327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs.
    Cai S; Li Z; Yu T; Xia M; Peng J
    Infect Drug Resist; 2018; 11():469-477. PubMed ID: 29662321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical effect of entecavir versus tenofovir in treatment of HBeAg-positive chronic hepatitis B patients with a high viral load: a comparative analysis].
    Shi H; Li XY; Zhu JY; Lin CS; Zhang Y
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):721-725. PubMed ID: 29108198
    [No Abstract]   [Full Text] [Related]  

  • 13. PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
    Chun HS; Papatheodoridis GV; Lee M; Lee HA; Kim YH; Kim SH; Oh YS; Park SJ; Kim J; Lee HA; Kim HY; Kim TH; Yoon EL; Jun DW; Ahn SH; Sypsa V; Yurdaydin C; Lampertico P; Calleja JL; Janssen H; Dalekos GN; Goulis J; Berg T; Buti M; Kim SU; Kim YJ
    J Hepatol; 2024 Jan; 80(1):20-30. PubMed ID: 37734683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B.
    Croagh CM; Bell SJ; Slavin J; Kong YX; Chen RY; Locarnini S; Desmond PV
    Liver Int; 2010 Sep; 30(8):1115-22. PubMed ID: 20492511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B.
    Li M; Gao Y; Yang L; Lin Y; Deng W; Jiang T; Bi X; Lu Y; Zhang L; Shen G; Liu R; Wu S; Chang M; Xu M; Hu L; Song R; Jiang Y; Yi W; Xie Y
    Front Immunol; 2022; 13():1024333. PubMed ID: 36203581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil.
    Mendes-Correa MC; Pinho JR; Gomes-Gouvea MS; da Silva AC; Guastini CF; Martins LG; Leite AG; Silva MH; Gianini RJ; Uip DE
    BMC Infect Dis; 2011 Sep; 11():247. PubMed ID: 21933423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between HBV viral load and severity of liver inflammation in patients with chronic hepatitis B virus infection].
    Xing TJ; Zhao KY; Li WT; Wang LJ; Lu FM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):954-960. PubMed ID: 37872091
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of pegylated-interferon alpha-2a treatment in patients with HBeAg-positive chronic hepatitis B and partial viral response to nucleoside analogue therapy].
    Li MH; Hu LP; Zhang L; Lu Y; Shen G; Wu SL; Chang M; Mu CQ; Wu YZ; Yang M; Song SJ; Zhang SF; Hua WH; Xie Y; Cheng J; Xu DZ
    Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):826-31. PubMed ID: 26743242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression.
    Huang CJ; Wu CF; Lan CY; Sung FY; Lin CL; Liu CJ; Liu HF; Yu MW
    PLoS One; 2013; 8(7):e70169. PubMed ID: 23936156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.